Cathleen McCabe MD: Clinical Trials

1 trial sponsored by Cathleen McCabe MD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Terminated 1

Follow Cathleen McCabe MD: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Investigation of the Dextenza 0.4mg Intracanalicular Insert Delivery System Used in Cataract Surgery
Dextenza 0.4mg intracanalicular Insert, Durezol 0.05% Ophthalmic Emulsion - Cataract
Phase 4TerminatedCathleen McCabe MD12020-12-012022-11-10

Conditions studied

Cataract (1)

Interventions

Calcium Dobesilate (1)  ·  difluprednate (1)

Countries

United States (1)

Top investigators

Cathleen M McCabe, MD (1)